DNMT3L and hepatocellular carcinoma: The results demonstrated a consistent downregulation of DNMT3L expression in HCC across all 20 datasets, with a statistically significant reduction observed in 19 of them (p < 0.05) (Fig. 1A and Additional file 2: Fig. S1).